» Articles » PMID: 8124814

Ischemic Preconditioning Protects Against Coronary Endothelial Dysfunction Induced by Ischemia and Reperfusion

Overview
Journal Circulation
Date 1994 Mar 1
PMID 8124814
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Repetitive, brief periods of ischemia and reperfusion ("preconditioning") increase the resistance of myocardial tissue to subsequent prolonged ischemic episodes and limit infarct size. We investigated whether preconditioning also protects against coronary endothelial dysfunction induced by ischemia and reperfusion.

Methods And Results: Experiments were performed in four groups of rats (n = 8 in each group): group 1 rats underwent sham surgery, group 2 rats were subjected to 20 minutes of left coronary artery occlusion without reperfusion, group 3 rats underwent 20 minutes of occlusion followed by 1 hour of reperfusion, and group 4 rats (preconditioning group) underwent the same protocol as group 3 rats, preceded by three cycles of 5 minutes of ischemia and 5 minutes of reperfusion. At the end of the experiments, coronary segments (internal diameter, 250 to 300 microns) were removed distal to the occlusion site and mounted in wire myographs for isometric tension recording. Relaxations induced by increasing concentrations of acetylcholine, the calcium ionophore A23187, or the nitric oxide (NO) donor SIN-1 were determined in arteries precontracted by serotonin. Basal NO release was estimated by measuring contractions to NG-nitro L-arginine methyl ester (L-NAME). In addition, we determined the effect of preconditioning on infarct size in two additional groups that were subjected to the same protocols as those of groups 3 and 4. In those animals, area at risk (India ink injection) and infarct size (triphenyltetrazolium stain) were determined by computerized analysis of enlarged sections after video acquisition. Preconditioning markedly limited infarct size (percent of area at risk: controls, 57 +/- 2; preconditioning, 2.2 +/- 0.6; P < .01). Ischemia (without or with reperfusion) or preconditioning did not affect the coronary responses to L-NAME, serotonin, A23187, or SIN-1. Ischemia without reperfusion did not modify the relaxations to acetylcholine (maximal relaxation: sham, 58 +/- 4%; ischemia, 56 +/- 7%; P = NS). In contrast, ischemia followed by reperfusion markedly impaired the response to acetylcholine (26 +/- 6%; P < .01 versus sham). This impaired response was restored by preconditioning (maximal relaxation: 59 +/- 9%; P = NS versus sham; P < .01 versus ischemia/reperfusion).

Conclusions: In addition to protecting myocardial cells, preconditioning also protects coronary endothelial cells against ischemia/reperfusion injury.

Citing Articles

Multi-omic analysis of the cardiac cellulome defines a vascular contribution to cardiac diastolic dysfunction in obese female mice.

Dona M, Hsu I, Meuth A, Brown S, Bailey C, Aragonez C Basic Res Cardiol. 2023; 118(1):11.

PMID: 36988733 PMC: 10060343. DOI: 10.1007/s00395-023-00983-6.


Protein Alterations in Cardiac Ischemia/Reperfusion Revealed by Spatial-Omics.

Mezger S, Mingels A, Soulie M, Peutz-Kootstra C, Bekers O, Mulder P Int J Mol Sci. 2022; 23(22).

PMID: 36430335 PMC: 9692276. DOI: 10.3390/ijms232213847.


Renal Delivery of Pharmacologic Agents During Machine Perfusion to Prevent Ischaemia-Reperfusion Injury: From Murine Model to Clinical Trials.

Franzin R, Stasi A, Fiorentino M, Simone S, Oberbauer R, Castellano G Front Immunol. 2021; 12:673562.

PMID: 34295329 PMC: 8290413. DOI: 10.3389/fimmu.2021.673562.


Mineralocorticoid receptor blockade normalizes coronary resistance in obese swine independent of functional alterations in K channels.

Goodwill A, Baker H, Dick G, McCallinhart P, Bailey C, Brown S Basic Res Cardiol. 2021; 116(1):35.

PMID: 34018061 PMC: 8552965. DOI: 10.1007/s00395-021-00879-3.


HS Pretreatment Is Promigratory and Decreases Ischemia/Reperfusion Injury in Human Microvascular Endothelial Cells.

Zicola E, Arrigo E, Mancardi D Oxid Med Cell Longev. 2021; 2021:8886666.

PMID: 33953839 PMC: 8068530. DOI: 10.1155/2021/8886666.